Trials / Sponsors / SynAct Pharma Aps
SynAct Pharma Aps
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Ant Rheumatoid Arthritis (RA) | Phase 2 | 2024-10-01 |
| Completed | A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inad Rheumatoid Arthritis | Phase 2 | 2022-11-30 |
| Completed | A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment Rheumatoid Arthritis | Phase 2 | 2022-09-26 |
| Recruiting | A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With i Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy | Phase 2 | 2020-08-31 |
| Completed | A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joi Rheumatoid Arthritis | Phase 2 | 2019-08-26 |